|
|
||||||||
Original Research Communication |
1 From the Pennington Biomedical Research Center, Baton Rouge, LA (GAB, JCL, MM-W, SRS, JV, YD, LdJ, JR, and ML), and The Procter & Gamble Company, Cincinnati (ALE and JCP).
Background: Dietary fat has been implicated as a risk factor for cardiovascular disease and obesity.
Objective: We evaluated the effect on body weight, body fat, lipids, glucose, and insulin of replacing dietary fat with olestra in moderately obese men.
Design: Forty-five healthy overweight men were randomly assigned to 1 of 3 diets: control diet (33% fat), fat-reduced diet (25% fat), or fat-substituted diet (one-third of dietary fat replaced by olestra to achieve a diet containing 25% metabolizable fat). Body fat was measured by dual-energy X-ray absorptiometry and visceral and subcutaneous abdominal fat by computed tomography.
Results: Thirty-six men completed the 9-mo study. Body weight and body fat in the fat-substituted group declined by a mean (± SEM) of 6.27 ± 1.66 and 5.85 ± 1.34 kg, respectively, over 9 mo compared with 3.8 ± 1.34 and 3.45 ± 1.0 kg in the control group and 1.79 ± 0.81 and 1.68 ± 0.75 kg in the fat-reduced diet group. At 9 mo, the mean difference in body fat between the fat-reduced and fat-substituted groups was -4.19 ± 1.19 kg (95% CI: -6.57, -1.81), that between the control and fat-substituted groups was -2.55 ± 1.21 kg (-0.13, -4.97), and that between the control and fat-reduced groups was 1.63 ± 1.18 kg (3.96, -0.70). The men eating the fat-reduced diet asked for almost no extra foods, in contrast with the significantly higher requests (P < 0.05) from both of the other 2 groups.
Conclusion: Replacement of dietary fat with olestra reduces body weight and total body fat when compared with a 25%-fat diet or a control diet containing 33% fat.
Key Words: Body composition dietary fat obesity feeding trial olestra men Ole Study
This article has been cited by other articles:
![]() |
G. A Bray, J.-P. Flatt, J. Volaufova, J. P DeLany, and C. M Champagne Corrective responses in human food intake identified from an analysis of 7-d food-intake records Am. J. Clinical Nutrition, December 1, 2008; 88(6): 1504 - 1510. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L Neuhouser, C. L Rock, A. R Kristal, R. E Patterson, D. Neumark-Sztainer, L. J Cheskin, and M. D Thornquist Olestra is associated with slight reductions in serum carotenoids but does not markedly influence serum fat-soluble vitamin concentrations Am. J. Clinical Nutrition, March 1, 2006; 83(3): 624 - 631. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W Krieger, H. S Sitren, M. J Daniels, and B. Langkamp-Henken Effects of variation in protein and carbohydrate intake on body mass and composition during energy restriction: a meta-regression 1 Am. J. Clinical Nutrition, February 1, 2006; 83(2): 260 - 274. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. T. Tulley, J. Vaidyanathan, J. B. Wilson, J. C. Rood, J. C. Lovejoy, M. M. Most, J. Volaufova, J. C. Peters, and G. A. Bray Daily Intake of Multivitamins during Long-Term Intake of Olestra in Men Prevents Declines in Serum Vitamins A and E but Not Carotenoids J. Nutr., June 1, 2005; 135(6): 1456 - 1461. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A. Bray Is There Something Special about Low-Carbohydrate Diets? Ann Intern Med, March 15, 2005; 142(6): 469 - 470. [Full Text] [PDF] |
||||
![]() |
G. A. Bray Low-Carbohydrate Diets and Realities of Weight Loss JAMA, April 9, 2003; 289(14): 1853 - 1855. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |